PMID: 890670Aug 1, 1977Paper

Endometrial stromal sarcomas

Cancer
M Yoonessi, W R Hart

Abstract

This study is a clinicopathologic evaluation of seven patients with endometrial stromal sarcoma of pure homologous type. Histologic distinction from endometrial stromatosis was based on the presence of high mitotic activity and nuclear anaplasia. One sarcoma appeared to have originated from invasive stromatosis. All patients died within 27 months although the tumor was judged to have been confined to the uterus at the time of hysterectomy in five patients. The aggressive clinical behavior and high mortality rate documented in this and other studies indicate that stromal sarcoma should be distinguished from the better differentiated and more indolent endometrial stromal tumor known as stromatosis or endolymphatic stromal myosis. It is suggested that surgery be supplemented by irradiation and/or chemotherapy as primary treatment for stromal sarcoma in view of its dismal prognosis.

References

Oct 15, 1974·American Journal of Obstetrics and Gynecology·E SakselaB J Procope
Oct 1, 1969·Cancer·A O BadibJ H Webster
Jan 1, 1966·American Journal of Obstetrics and Gynecology·L A AaroM B Dockerty
Feb 1, 1959·American Journal of Obstetrics and Gynecology·W B OBER, H M TOVELL
Jul 1, 1962·Obstetrics and Gynecology·J G BOUTSELIS, J C ULLERY
Jan 9, 1959·Annals of the New York Academy of Sciences·W B OBER

❮ Previous
Next ❯

Citations

Jan 1, 1980·Urologic Radiology·S M GoldmanJ O Salik
Oct 1, 1985·European Journal of Obstetrics, Gynecology, and Reproductive Biology·P G Betta, F Robutti
May 1, 1990·European Journal of Obstetrics, Gynecology, and Reproductive Biology·B LarsonF Pettersson
Jan 31, 1992·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M E VierhoutA C Drogendijk
Aug 1, 1979·Gynecologic Oncology·R YazigiJ J Barlow
Nov 1, 1988·Cancer Genetics and Cytogenetics·P Dal CinA A Sandberg
May 1, 1992·Cancer Genetics and Cytogenetics·A E FresiaC A Griffin
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R. BlomC. Guerrieri
Feb 1, 1987·American Journal of Obstetrics and Gynecology·A L CovensH H Allen
Jul 1, 1980·International Journal of Radiation Oncology, Biology, Physics·O M Salazar, M E Dunne
Mar 1, 1988·Current Problems in Cancer·J S BerekR C Young
Jan 22, 2005·Gynecologic Oncology·J RiopelB Têtu
Aug 1, 1991·Human Pathology·P B Clement
Jan 1, 1990·Gynecologic Oncology·J L MansiC Fisher
Nov 1, 1989·Gynecologic Oncology·S L StyronW K Linville
Oct 1, 1989·Gynecologic Oncology·P A De FuscoS S Cha
Jul 1, 1984·Gynecologic Oncology·M J MarcheseH C Frick
Jan 1, 1990·Gynecologic Oncology·A BerchuckJ L Lewis
Aug 22, 2006·Gynecologic Oncology·Frederic AmantIgnace Vergote
Feb 1, 1989·Gynecologic Oncology·E TainaA Viitanen
Oct 31, 2014·Histopathology·Cheng-Han Lee, Marisa R Nucci
Sep 1, 1978·Cancer·O M SalazarJ Rudolph
Oct 1, 1984·Gynecologic Oncology·W P FlemingG W Morley
Apr 9, 2005·World Journal of Gastroenterology : WJG·Yuki AsadaShigeru Kohno
Feb 25, 2010·Advances in Anatomic Pathology·Ivy Chew, Esther Oliva
May 10, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M ArenasA Biete
Oct 15, 2013·The American Journal of Surgical Pathology·Ramya P MasandAnais Malpica
Dec 6, 2012·The American Journal of Surgical Pathology·Emanuela D'AngeloJaime Prat
Mar 17, 2007·Pathology·Farid MoinfarFattaneh A Tavassoli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.